ZFA-Logo

Identifying safety problems in the General Practice – analysis of the treatment process of oral anticoagulation therapy

DOI: 10.3238/zfa.2009.0148

german translation / full article

Martin Beyer, Ferdinand Michael Gerlach, Sebastian Harder, Julia Rohe, Eckart Blauth, Barbara Hoffmann, Kristina Saal

Keywords: anticoagulants drug monitoring safety management family practice

Abstract

Background: Oral anticoagulants (OAC) are high alert medications and thus relevant to safety in general practice. In an explorative retrospective observational study the process of treatment was examined for safety gaps, medication errors, interaction risks and contraindications.

Methods: A model of the long-term treatment process was developed using the parameters documentation, therapy decision, patient participation and monitoring strategy. Using 3 international guidelines, 30 process indicators were generated to define safe oral anticoagulation treatment. Data collection was via chart reviews and interviews with patients and general practitioners (GP). Detected irregularities were checked for potential safety risks.

Results: Sixteen GP recruited 100 patients taking OAC. In all practices treatment routines were established, but safety gaps were identified mainly in documentation, and patient participation and knowledge. The target INR-range was not documented in the records of 81 patients; the current medication dose was missing in the records of 55, and an OAC warning was neglected in 70 cases. Thirty-six patients were not informed about the risks and peculiarities of OAC therapy. Contraindications were ignored in 2 cases and interaction risks in 18. Three patients received intramuscular injections. Eighty-seven patients received INR-controls at least every 4 weeks, but in about 30 % of these the reaction to abnormal INR-results was inappropriate.

Conclusions: Room for improvement exists in monitoring, documentation quality and patient involvement. Structured documentation of important process steps for OAC use and the specific involvement of patients seem sensible to increase treatment safety. However, the effectiveness of these actions should be tested in controlled trials.


(State: 07.06.2011)

Latest Issue 1/2020

In Focus

  • Increasing Organ Donor Registration Through Nudging in a Family Practice
  • Treatment of Depression from the View of Family Physicians
  • Medical Action as Ethical Principle